Page last updated: 2024-08-24

adibendan and Cardiac Output, Low

adibendan has been researched along with Cardiac Output, Low in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mende, U; Meyer, W; Neumann, J; Nose, M; Schmitz, W; Scholz, H; Starbatty, J; Stein, B; von der Leyen, H; Wenzlaff, H1

Other Studies

1 other study(ies) available for adibendan and Cardiac Output, Low

ArticleYear
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    Naunyn-Schmiedeberg's archives of pharmacology, 1991, Volume: 344, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Benzimidazoles; Calcium; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Oxindoles; Phosphodiesterase Inhibitors; Piperazines; Pyridazines; Pyridones

1991